Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-028344
Filing Date
2021-11-15
Accepted
2021-11-15 08:44:06
Documents
38
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 511759
2 ex31-1.htm EX-31.1 18291
3 ex31-2.htm EX-31.2 18634
4 ex32-1.htm EX-32.1 4805
5 ex32-2.htm EX-32.2 4854
  Complete submission text file 0001493152-21-028344.txt   2444601

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE mbot-20210930.xsd EX-101.SCH 18341
7 XBRL CALCULATION FILE mbot-20210930_cal.xml EX-101.CAL 29947
8 XBRL DEFINITION FILE mbot-20210930_def.xml EX-101.DEF 58466
9 XBRL LABEL FILE mbot-20210930_lab.xml EX-101.LAB 166286
10 XBRL PRESENTATION FILE mbot-20210930_pre.xml EX-101.PRE 121332
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 338023
Mailing Address 25 RECREATION PARK DR SUITE 108 HINGHAM MA 02043
Business Address 25 RECREATION PARK DR SUITE 108 HINGHAM MA 02043 908-938-5561
Microbot Medical Inc. (Filer) CIK: 0000883975 (see all company filings)

EIN.: 943078125 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19871 | Film No.: 211406639
SIC: 2836 Biological Products, (No Diagnostic Substances)